Gestational trophoblastic disease.

Gestational trophoblastic disease consists of a broad spectrum of conditions ranging from an uncomplicated partial hydatidiform molar pregnancy to stage IV choriocarcinoma with cerebral metastases. Fortunately, with the advent of combination chemotherapy, the patient with advanced-stage disease has a significant chance of achieving complete remission. In addition, several studies have demonstrated that patients with a history of gestational trophoblastic neoplasia do not experience an increased risk of complications with future pregnancies. Patients who have undergone chemotherapy do not seem to experience an increase in the risk for congenital anomalies in their offspring. Patients with a history of hydatidiform molar pregnancy should be advised that they are at increased risk of future molar pregnancies, with a risk of 1% in subsequent gestations after one molar pregnancy and a risk as high as 23% after two molar gestations. Although patients should be reassured regarding their reproductive future, they should be advised to seek prompt medical attention once gestation is suspected so that an early work-up can be initiated if pregnancy is confirmed.

[1]  G T Ross,et al.  A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. , 1972, American journal of obstetrics and gynecology.

[2]  M. Seckl,et al.  Treatment of gestational trophoblastic disease. , 1997, General & diagnostic pathology.

[3]  J. Lurain,et al.  Treatment of High-Risk Gestational Trophoblastic Disease With Methotrexate, Actinomycin D, and Cyclophosphamide Chemotherapy , 1985, Obstetrics and gynecology.

[4]  T. Benedetti,et al.  Hemodynamic observations in evacuation of molar pregnancy. , 1980, American journal of obstetrics and gynecology.

[5]  R. Fisher,et al.  Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. , 1992, British Journal of Cancer.

[6]  Mortakis Ae,et al.  Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures. , 1990 .

[7]  Driscoll Sg Problems and pitfalls in the histopathologic diagnosis of gestational trophoblastic lesions. , 1987 .

[8]  N. Ordóñez,et al.  Multiple nodules of intermediate trophoblast following hydatidiform moles. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[9]  K. Bagshawe,et al.  Immunodiagnosis and monitoring of gonadotrophin‐producing metastases in the central nervous system , 1976, Cancer.

[10]  K. Bilek,et al.  Clinicopathologic analysis of gestational trophoblastic disease--report of 158 cases. , 1997, General & diagnostic pathology.

[11]  R. Berkowitz,et al.  Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses. , 1994, The Journal of reproductive medicine.

[12]  R. Hertz,et al.  Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  S. Tsao,et al.  Current understandings of the molecular genetics of gestational trophoblastic diseases. , 2002, Placenta.

[14]  W. Mclean,et al.  Neonatal intracranial choriocarcinoma. Case report. , 1971, Journal of neurosurgery.

[15]  K. Miyazawa,et al.  Partial hydatidiform moles: a review. , 1987, Obstetrical & gynecological survey.

[16]  W. H. Sheldon,et al.  Hydatidiform mole; a pathologico-clinical correlation of 200 cases. , 1947, American journal of obstetrics and gynecology.

[17]  R. Berkowitz,et al.  Outcome of pregnancies occurring within 1 year of hydatidiform mole. , 1999, Obstetrics and gynecology.

[18]  W. Creasman,et al.  Hydatidiform Mole. Diagnosis, Management, and Long‐Term Followup of 347 Patients , 1975, Obstetrics and gynecology.

[19]  T. Mungan,et al.  Hydatidiform mole: clinical analysis of 310 patients , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[20]  F. Montz,et al.  Initial management of hydatidiform mole. , 1988, American journal of obstetrics and gynecology.

[21]  C. Stringer,et al.  High-risk metastatic gestational trophoblastic disease: further stratification into two clinical entities. , 1989, Gynecologic oncology.

[22]  R. Berkowitz,et al.  Risk factors for complete molar pregnancy from a case-control study. , 1985, American journal of obstetrics and gynecology.

[23]  R. Berkowitz,et al.  Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. , 1984, Gynecologic oncology.

[24]  Begent Rh,et al.  The management of high-risk choriocarcinoma. , 1982 .

[25]  U. Surti,et al.  The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. , 1978, American journal of obstetrics and gynecology.

[26]  T. Herzog,et al.  Gestational trophoblastic diseases: new standards for therapy , 2000, Current opinion in oncology.

[27]  S. R. Reynolds Hydatidiform mole: a vascular congenital anomaly. , 1976, Obstetrics and gynecology.

[28]  R. Berkowitz,et al.  Choriocarcinoma following term gestation. , 1984, Gynecologic oncology.

[29]  E. Newlands,et al.  Central nervous system metastases of choriocarcinoma. 23 Years' experience at Charing Cross Hospital , 1983, Cancer.

[30]  J. Lewis,et al.  Management of high-risk gestational trophoblastic disease--the Memorial Hospital experience. , 1997, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[31]  Bagshawe Kd High-risk metastatic trophoblastic disease. , 1988 .

[32]  D. Rao,et al.  Complete hydatidiform mole in Hawaii: An epidemiological study , 1984, Genetic epidemiology.

[33]  E. Newlands,et al.  Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989 , 1992 .

[34]  I. McNeish,et al.  Twenty-five years' clinical experience with placental site trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[35]  T. Mcdonald,et al.  Modern management of gestational trophoblastic disease. , 1983, Obstetrical & gynecological survey.

[36]  J. Schlaerth,et al.  Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. , 1984, Gynecologic oncology.

[37]  I. Shih,et al.  Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[38]  G. Srivastava,et al.  Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas. , 1994, The Journal of reproductive medicine.

[39]  J. Robben,et al.  Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[40]  U. Surti,et al.  Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. , 2000, American journal of human genetics.

[41]  R. Berkowitz,et al.  Subsequent pregnancy experience in patients with gestational trophoblastic disease. New England Trophoblastic Disease Center, 1965-1992. , 1994, The Journal of reproductive medicine.

[42]  L. Clayton,et al.  Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease. , 1982, Obstetrics and gynecology.

[43]  R. Berkowitz,et al.  Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease , 1986 .

[44]  H. Ha,et al.  Gestational trophoblastic tumors of the uterus: MR imaging--pathologic correlation. , 1995, Gynecologic oncology.

[45]  K. Ohama,et al.  XY and XX complete moles: clinical and morphologic correlations. , 1984, American journal of obstetrics and gynecology.

[46]  D. Goldstein The chemotherapy of gestational trophoblastic disease: principles of clinical management. , 1972, JAMA.

[47]  R. Berkowitz,et al.  Evolving concepts of molar pregnancy. , 1991, The Journal of reproductive medicine.

[48]  R. Berkowitz,et al.  Metastatic Gestational Trophoblastic Disease: Experience at the New England Trophoblastic Disease Center, 1965 to 1985 , 1987, Obstetrics and gynecology.

[49]  S. Shapiro,et al.  Oral contraceptive use and risk of gestational trophoblastic tumors. , 1999, Journal of the National Cancer Institute.

[50]  R. Berkowitz,et al.  Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. , 1998, The Journal of reproductive medicine.

[51]  T. Toth,et al.  High incidence of triploidy in in-vitro fertilized oocytes from a patient with a previous history of recurrent gestational trophoblastic disease. , 1996, Human reproduction.

[52]  B. Yuen,et al.  Molar pregnancy in British Columbia: estimated incidence and postevacuation regression patterns of the beta subunit of human chorionic gonadotropin. , 1981, American journal of obstetrics and gynecology.

[53]  C. Sun,et al.  Resection of pulmonary metastatic choriocarcinoma in 43 drug-resistant patients. , 1985, The Annals of thoracic surgery.

[54]  R. Berkowitz,et al.  Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. , 1999, Gynecologic oncology.

[55]  F. Landoni,et al.  EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). , 1988, Gynecologic oncology.

[56]  C. Théodore,et al.  Treatment of high‐risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide , 1989, Cancer.

[57]  F. Chen Molar pregnancy and living normal fetus coexisting until term: prenatal biochemical and sonographic diagnosis. , 1997, Human reproduction.

[58]  H. Ma,et al.  Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. , 1985, American journal of obstetrics and gynecology.

[59]  D. Mutch,et al.  Role of Computed Axial Tomography of the Chest in Staging Patients With Nonmetastatic Gestational Trophoblastic Disease , 1986, Obstetrics and gynecology.

[60]  C. Hammond,et al.  Renal Metastases of Gestational Trophoblastic Disease: A Report of Eight Cases , 1988, Obstetrics and Gynecology.

[61]  S. Lawler,et al.  HETEROZYGOUS COMPLETE HYDATIDIFORM MOLES: DO THEY HAVE A WORSE PROGNOSIS THAN HOMOZYGOUS COMPLETE MOLES? , 1984, The Lancet.

[62]  R. A. Fisher,et al.  Gestational trophoblastic disease. Molecular and genetic studies. , 1998, The Journal of reproductive medicine.

[63]  R. Fisher,et al.  Management of placental site trophoblastic tumors. , 1998, The Journal of reproductive medicine.

[64]  A. Dukovski [Non-trophoblastic tumors of the placenta]. , 1994, Akusherstvo i ginekologiia.

[65]  G. Rustin,et al.  The role of low‐dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT) , 1990 .

[66]  Mccluggage,et al.  Localization of the cellular expression of inhibin in trophoblastic tissue , 1998, Histopathology.

[67]  J. Wong-You-Cheong,et al.  Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report. , 2002, Gynecologic oncology.

[68]  R. Young,et al.  The prognostic significance of adenomyosis in endometrial carcinoma. , 1984, Gynecologic oncology.

[69]  N. Sebire,et al.  Pseudo‐partial moles: placental stem vessel hydrops and the association with Beckwith–Wiedemann syndrome and complete moles , 2001, Histopathology.

[70]  A. Cheung,et al.  Choriocarcinoma Co‐Existent with an Intact Pregnancy: Case Report and Review of the Literature , 1999, The journal of obstetrics and gynaecology research.

[71]  R. Berkowitz,et al.  Duplex ultrasonography for persistent gestational trophoblastic tumor. , 1991, The Journal of reproductive medicine.

[72]  D. P. Goldstein,et al.  The role of thoracotomy in the management of patients with chest metastases from gestational trophoblastic disease. , 1972, The Journal of thoracic and cardiovascular surgery.

[73]  A. Cheung,et al.  Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. , 1994, Gynecologic oncology.

[74]  E. Newlands,et al.  Presentation and management of choriocarcinoma after nonmolar pregnancy , 1995, British journal of obstetrics and gynaecology.

[75]  R. Berkowitz,et al.  Natural History of Partial Molar Pregnancy , 1985, Obstetrics and gynecology.

[76]  Y. Nose,et al.  Prophylactic chemotherapy for hydatidiform mole five to 15 years follow‐up , 1986, Cancer.

[77]  R. Osathanondh,et al.  Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole , 1984 .

[78]  R. Fisher,et al.  Placental site trophoblastic tumor: molecular analysis and clinical experience. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[79]  R. Berkowitz,et al.  Management of complete molar pregnancy. , 1987, The Journal of reproductive medicine.

[80]  P. Jacobs,et al.  Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole , 1982, Annals of human genetics.

[81]  R. Berkowitz,et al.  Low-risk metastatic gestational trophoblastic tumors. , 1995, Seminars in oncology.

[82]  A. Rademaker,et al.  Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis. , 1991, American journal of obstetrics and gynecology.

[83]  D. Green,et al.  Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. , 1991, The New England journal of medicine.

[84]  J. Lewis Choriocarcinoma: a success story for chemotherapy. , 1980, International journal of radiation oncology, biology, physics.

[85]  D. Goldstein Five years' experience with the prevention of trophoblastic tumors by the prophylactic use of chemotherapy in patients with molar pregnancy. , 1970, Clinical obstetrics and gynecology.

[86]  Y. Tomoda,et al.  Surgical indications for resection in pulmonary metastasis of choriocarcinoma , 1980, Cancer.

[87]  R. Berkowitz,et al.  Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. , 2002, The Journal of reproductive medicine.

[88]  U. Surti,et al.  The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. , 1978, American journal of obstetrics and gynecology.

[89]  H. Homesley Development of single-agent chemotherapy regimens for gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.

[90]  C. la Vecchia,et al.  Dietary factors and risk of trophoblastic disease. , 1988, American journal of obstetrics and gynecology.

[91]  G. Rustin,et al.  Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. , 1984, British medical journal.

[92]  C. Théodore,et al.  Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high‐risk. Gestational trophoblastic tumors , 1989, Cancer.

[93]  R. Smith,et al.  Choriocarcinoma. Absolute 5 year survival rates of 122 patients treated by hysterectomy. , 1963, American journal of obstetrics and gynecology.

[94]  K. Bilek,et al.  Histologic classification and staging of gestational trophoblastic disease. , 1997, General & diagnostic pathology.

[95]  H. Fox Gestational trophoblastic disease , 1997, BMJ.

[96]  E S Newlands,et al.  EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[97]  S. Sekiya,et al.  Adjuvant Hysterectomy in Low‐Risk Gestational Trophoblastic Disease , 2001, Obstetrics and gynecology.

[98]  R. Berkowitz,et al.  p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. , 1998, The Journal of reproductive medicine.

[99]  E. Kohorn How soon is it safe to undertake pregnancy after trophoblastic tumor? , 1999, Gynecologic oncology.

[100]  J. P. Calvert,et al.  Histopathological diagnosis of hydatidiform mole , 1983, The Journal of pathology.

[101]  G. Ross,et al.  SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN. , 1965, American journal of obstetrics and gynecology.

[102]  S. Okada,et al.  Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. , 1999, Human pathology.

[103]  W. Creasman,et al.  Treatment of metastatic trophoblastic disease: good and poor prognosis. , 1973, American journal of obstetrics and gynecology.

[104]  R. Berkowitz,et al.  Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. , 1996, American journal of clinical pathology.

[105]  R. Scully,et al.  Trophoblastic pseudotumor: a reappraisal. , 1981, The American journal of surgical pathology.

[106]  R. Berkowitz,et al.  Psychological, social and sexual effects of gestational trophoblastic disease on patients and their partners. , 1994, The Journal of reproductive medicine.

[107]  R. Berkowitz,et al.  Quality of life after gestational trophoblastic disease. , 2002, The Journal of reproductive medicine.

[108]  Wong Lc,et al.  Hepatic metastases in gestational trophoblastic disease. , 1986 .

[109]  I. Shih,et al.  Placental site nodule and characterization of distinctive types of intermediate trophoblast. , 1999, Human pathology.

[110]  N. Wake,et al.  Malignant potential of homozygous and heterozygous complete moles. , 1984, Cancer research.

[111]  B. Wren Hormonal therapy following female genital tract cancer , 1993, International Journal of Gynecologic Cancer.

[112]  E. Lehman,et al.  Salvage surgery for chemorefractory gestational trophoblastic disease. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[113]  U. Nitz,et al.  Metastatic choriocarcinoma in a postmenopausal woman. , 1996, Gynecologic Oncology.

[114]  H. Ngan,et al.  Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen. , 1994, Journal of clinical pathology.

[115]  A. Senthilselvan,et al.  Hydatidiform mole in the elderly: Hysterectomy or evacuation? , 1989, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[116]  R. Berkowitz,et al.  A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. , 1992, Obstetrics and gynecology.

[117]  I. Shih,et al.  HLA-G Immunoreactivity Is Specific for Intermediate Trophoblast in Gestational Trophoblastic Disease and Can Serve as a Useful Marker in Differential Diagnosis , 2002, The American journal of surgical pathology.

[118]  J. Lurain High-risk metastatic gestational trophoblastic tumors. Current management. , 1994, The Journal of reproductive medicine.

[119]  K. Hatch,et al.  Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate. , 1987 .

[120]  H. Homesley Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease. , 1998, The Journal of reproductive medicine.

[121]  N. Sebire,et al.  Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: case report. , 2002, Human reproduction.

[122]  J. Chueh,et al.  Delayed-interval delivery in a quadruplet pregnancy after intrauterine death of a partial molar pregnancy and preterm delivery. A case report. , 1998, The Journal of reproductive medicine.

[123]  L. Jm,et al.  Genetic aspects of gestational trophoblastic diseases: a general overview with emphasis on new approaches in determining genetic composition. , 1997 .

[124]  L. Twiggs,et al.  Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study) , 1989, American journal of obstetrics and gynecology.

[125]  R. Berkowitz,et al.  Gestational trophoblastic diseases. , 1989, Seminars in oncology.

[126]  M. Novy,et al.  Cardiorespiratory responses to pregnancy and exercise in normal women and patients with heart disease. , 1973, American journal of obstetrics and gynecology.

[127]  K. Bagshawe Risk and prognostic factors in trophoblastic neoplasia , 1976, Cancer.

[128]  F. Paradinas,et al.  The diagnosis and prognosis of molar pregnancy: The experience of the National Referral Centre in London , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[129]  M. Seckl,et al.  Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[130]  R. Scully,et al.  Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. , 1984, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[131]  E. Swisher,et al.  Metastatic placental site trophoblastic tumor: long-term remission in a patient treated with EMA/CO chemotherapy. , 1998, Gynecologic oncology.

[132]  C. Morrow,et al.  Low-risk metastatic gestational trophoblastic disease. , 1988, Obstetrics and gynecology clinics of North America.

[133]  W. Ober,et al.  The early history of choriocarcinoma. , 1961, Journal of the history of medicine and allied sciences.

[134]  E. Newlands,et al.  Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984) , 1986, British journal of obstetrics and gynaecology.

[135]  A. Lilienfeld,et al.  Inter‐ and Intra‐Pathologist Variability in the Diagnosis of Gestational Trophoblastic Neoplasia , 1987, Obstetrics and gynecology.

[136]  R. Kurman,et al.  Tumors of the uterine corpus and gestational trophoblastic disease , 1992 .

[137]  J. Weed,et al.  Arteriography and Infusional Chemotherapy in Localized Trophoblastic Disease , 1975, Obstetrics and gynecology.

[138]  Y. Zalel,et al.  Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[139]  A. Cheung,et al.  p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. , 1998, Journal of clinical pathology.

[140]  K. Brace The Role of Irradiation in the Treatment of Metastatic Trophoblastic Disease , 1968 .

[141]  P. Giacalone,et al.  High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. , 1995, Gynecologic oncology.

[142]  M. Oshimura,et al.  Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma , 1997, Oncogene.

[143]  R. Berkowitz,et al.  Case-control study of risk factors for partial molar pregnancy. , 1995, American journal of obstetrics and gynecology.

[144]  T. Hassold,et al.  Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. , 1998, Human pathology.

[145]  H. Ball,et al.  Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole , 1993, Obstetrics and gynecology.

[146]  Anthony F. Shaker,et al.  Twin pregnancy with a complete hydatidiform mole and co-existing fetus following in-vitro fertilization: case report. , 1999, Human reproduction.

[147]  R. Fisher,et al.  Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. , 1993, American journal of obstetrics and gynecology.

[148]  D. Mutch,et al.  Recurrent gestational trophoblastic disease. Experience of the southeastern regional trophoblastic disease center , 1990, Cancer.

[149]  R. Berkowitz,et al.  Repetitive Complete and Partial Hydatidiform Mole , 1989, Obstetrics and gynecology.

[150]  R. Gelber,et al.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.

[151]  A. Altintaş,et al.  Placental-site trophoblastic tumor. Principles of diagnosis, clinical behaviour and treatment. , 1995, European journal of gynaecological oncology.

[152]  T. Nagasaka,et al.  p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. , 1998, Placenta.

[153]  L. Twiggs,et al.  Single‐dose actinomycin‐D treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the gynecologic oncology group , 1987, Cancer.

[154]  R. Berkowitz,et al.  Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease. , 1988, Gynecologic oncology.

[155]  M. Gail,et al.  Early menopause in long-term survivors of cancer during adolescence , 1992 .

[156]  S. Pittaluga,et al.  Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. , 1993, Journal of clinical pathology.

[157]  Y. Soong,et al.  Clinical management of a quadruplet pregnancy combining a triplet pregnancy with a classical hydatidiform mole: case report and review of literature , 1999, Prenatal diagnosis.

[158]  T. Inoue,et al.  CD9 is involved in invasion of human trophoblast-like choriocarcinoma cell line, BeWo cells. , 1999, Molecular human reproduction.

[159]  T. Bilgin,et al.  Recurrent molar pregnancy , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[160]  L. Cole,et al.  Phantom hCG and phantom choriocarcinoma. , 1998, Gynecologic oncology.

[161]  S. Lauchlan,et al.  Clinical characteristics of placental site trophoblastic tumor (PSTT). , 1988, Gynecologic oncology.

[162]  I. Shih,et al.  Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. , 1998, Human pathology.

[163]  J. Lurain,et al.  Natural history of hydatidiform mole after primary evacuation. , 1983, American journal of obstetrics and gynecology.

[164]  T. Kajii,et al.  Hydatidiform mole: two entities , 1977 .

[165]  R. Berkowitz,et al.  Reproductive experience after complete and partial molar pregnancy and gestational trophoblastic tumors. , 1991, The Journal of reproductive medicine.

[166]  A. Ayhan,et al.  Pregnancy after chemotherapy for gestational trophoblastic disease. , 1990, The Journal of reproductive medicine.

[167]  W. Small,et al.  Gestational trophoblastic disease metastatic to the brain. , 1996, Radiology.

[168]  H. Acosta-Sison Ab initio choriocarcinoma; two unusual cases. , 1959, Obstetrics and gynecology.

[169]  L. Cole,et al.  False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations , 2000, The Lancet.

[170]  R. Berkowitz,et al.  Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. , 1990, Gynecologic oncology.

[171]  U. Surti,et al.  PATIENT WITH PARTIAL MOLE REQUIRING CHEMOTHERAPY , 1978, The Lancet.

[172]  G. Rustin,et al.  Surgery and chemotherapy in the management of placental site tumor. , 1990, Gynecologic oncology.

[173]  C. Hammond,et al.  Malignant Potential of Gestational Trophoblastic Disease at the Extreme Ages of Reproductive Life , 1984, Obstetrics and gynecology.

[174]  N. Sebire,et al.  The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. , 2002, Human molecular genetics.

[175]  S. Lawler,et al.  Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole , 1990, The Lancet.

[176]  L. Twiggs,et al.  Metastatic placental site trophoblastic tumor , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[177]  I. Konishi,et al.  Epithelioid trophoblastic tumor metastatic to the vagina: an immunohistochemical and ultrastructural study. , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[178]  I. Shih,et al.  Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. , 1998, The American journal of surgical pathology.

[179]  J. Fiorica,et al.  Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid. , 1993, European journal of gynaecological oncology.

[180]  C. E. Wilde,et al.  INFUSION THERAPY FOR PELVIC TROPHOBLASTIC TUMOURS , 1964, The Journal of obstetrics and gynaecology of the British Commonwealth.

[181]  R. Berkowitz,et al.  Clinical Experience With Placental Site Trophoblastic Tumors at the New England Trophoblastic Disease Center , 1988, Obstetrics and gynecology.

[182]  Y. Moon,et al.  Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. , 1986, Obstetrics and gynecology.

[183]  N. Wake,et al.  Androgenesis as a cause of hydatidiform mole. , 1978, Journal of the National Cancer Institute.

[184]  Ali Ms Letter: Geriatrics is medicine. , 1974, The Lancet.

[185]  S. Sjamsuddin,et al.  Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. , 1984, Advances in experimental medicine and biology.

[186]  R. Fisher,et al.  Diploid hydatidiform moles with fetal red blood cells in molar villi. 2—genetics , 1997, The Journal of pathology.

[187]  J. Weed,et al.  The role of operation in the current therapy of gestational trophoblastic disease. , 1980, American journal of obstetrics and gynecology.

[188]  S. Braun,et al.  Successful treatment of malignant placental site trophoblastic tumor with combined cytostatic-surgical approach: case report and review of literature. , 1999, Gynecologic oncology.

[189]  T. Kameda,et al.  Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. , 1991, Gynecologic oncology.

[190]  M. J. Webb,et al.  TREATMENT OF PLACENTAL SITE TROPHOBLASTIC TUMOR WITH HYSTEROTOMY AND UTERINE RECONSTRUCTION , 1996, Obstetrics and gynecology.

[191]  J. Lurain,et al.  Gestational Trophoblastic Disease: Treatment Results at the Brewer Trophoblastic Disease Center , 1982, Obstetrics and gynecology.

[192]  R. Eckstein,et al.  Placental site trophoblastic tumour (trophoblastic pseudotumour): a study of four cases requiring hysterectomy including one fatal case , 1982, Histopathology.

[193]  H Fox,et al.  Can histopathologists reliably diagnose molar pregnancy? , 1993, Journal of clinical pathology.

[194]  Goldstein Ja,et al.  Complete Hydatidiform Mole With a Coexistent Healthy, Viable Fetus Near Term: A Case Report , 1996 .

[195]  M. Glezerman,et al.  Metastatic trophoblastic disease following partial hydatidiform mole: case report and literature review. , 1999, Gynecologic oncology.

[196]  T. Khong Chorangioma with trophoblastic proliferation , 2000, Virchows Archiv.

[197]  J. Soper Surgical therapy for gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.

[198]  Soper Jt Identification and management of high-risk gestational trophoblastic disease , 1995 .

[199]  G. Coukos,et al.  Complete hydatidiform mole. A disease with a changing profile. , 1999, The Journal of reproductive medicine.

[200]  F. Witter,et al.  Complete hydatidiform mole and surviving coexistent twin. , 1996, Obstetrical & gynecological survey.

[201]  C. la Vecchia,et al.  Increased frequency of complete hydatidiform mole in women with repeated abortion. , 1988, Gynecologic oncology.

[202]  R. Scully,et al.  Placental-Site Trophoblastic Tumor: Current Status , 1984, Clinical obstetrics and gynecology.

[203]  I. Shih,et al.  Expression of melanoma cell adhesion molecule in intermediate trophoblast. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[204]  B. Schwarz,et al.  Sonographic Findings and Clinical Correlations in Molar Pregnancy , 1980, Obstetrics and gynecology.

[205]  S. Povey,et al.  Genetic studies on hydatidiform moles. I. The origin of partial moles. , 1982, Cancer genetics and cytogenetics.

[206]  F. Parazzini,et al.  Parental age and risk of complete and partial hydatidiform mole , 1986, British journal of obstetrics and gynaecology.

[207]  M. Dinis,et al.  Placental site trophoblastic tumour: the value of transvaginal colour and pulsed Doppler sonography (TV-CDS) in its diagnosis: case report. , 1997, European journal of gynaecological oncology.

[208]  C. Théodore,et al.  Prognostic factors in gestational trophoblastic tumors. A multivariate analysis , 1988, Cancer.

[209]  H. Frierson,et al.  Detection of the alpha-subunit of inhibin in trophoblastic neoplasia. , 1999, Human pathology.

[210]  M. Bygdeman 10 Prostaglandin analogues and their uses , 1992 .

[211]  R. Berkowitz,et al.  Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. , 1998, The Journal of reproductive medicine.

[212]  K. Leveno,et al.  Sinusoidal Fetal Heart Rate Pattern After Intrauterine Transfusion , 1984, Obstetrics and gynecology.

[213]  B. Mychalczak,et al.  Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. , 1998, Gynecologic oncology.

[214]  Pratt Ra,et al.  Cerebral necrosis following irradiation and chemotherapy for metastatic choriocarcinoma. , 1977 .

[215]  E. Kohorn The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment , 2000, International Journal of Gynecologic Cancer.

[216]  A. Ostör "God's first cancer and man's first cure": milestones in gestational trophoblastic disease. , 1996, Anatomic pathology.

[217]  J. Roberts,et al.  Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. , 1996, American journal of obstetrics and gynecology.

[218]  R. Berkowitz,et al.  Gestational trophoblastic disease , 1995, Cancer.

[219]  Janice M. Lage,et al.  Gestational Trophoblastic Disease: New Approaches to Diagnosis , 1995 .

[220]  U. Surti,et al.  Human chorionic gonadotropin levels in complete and partial hydatidiform moles and in nonmolar abortuses. , 1984, American journal of obstetrics and gynecology.

[221]  R. Coleman,et al.  The presentation and management of post-partum choriocarcinoma , 1999, British Journal of Cancer.

[222]  Young Tae Kim,et al.  Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases , 2000, Cancer.

[223]  A. Rademaker,et al.  The Role of Contraception in the Development of Postmolar Gestational Trophoblastic Tumor , 1991, Obstetrics and gynecology.

[224]  R. A. Fisher,et al.  Genetic studies on hydatidiform moles II. The origin of complete moles , 1982, Annals of human genetics.

[225]  I. Bukovsky,et al.  Placental-site trophoblastic tumor following metastatic gestational trophoblastic neoplasia. , 1996, Gynecologic oncology.

[226]  L. Vejerslev Clinical management and diagnostic possibilities in hydatidiform mole with coexistent fetus. , 1991, Obstetrical & gynecological survey.

[227]  A. Cheung,et al.  Telomerase activity in gestational trophoblastic disease. , 1999, Journal of clinical pathology.

[228]  E. Newlands,et al.  Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[229]  D. Fishman,et al.  Management of Twin Pregnancies Consisting of a Complete Hydatidiform Mole and Normal Fetus , 1998, Obstetrics and gynecology.

[230]  R. Berkowitz,et al.  Flow Cytometric Analysis of DNA Content in Partial Hydatidiform Moles With Persistent Gestational Trophoblastic Tumor , 1991, Obstetrics and gynecology.

[231]  D. Olive,et al.  Choriocarcinoma associated with term gestation. , 1984, American journal of obstetrics and gynecology.

[232]  R. Berkowitz,et al.  Current management of complete and partial molar pregnancy. , 1994, The Journal of reproductive medicine.

[233]  S. Behmard,et al.  DISCREPANCIES IN THE HISTOLOGICAL DIAGNOSIS OF HYDATIDIFORM MOLE , 1979, British journal of obstetrics and gynaecology.

[234]  A. Perkins,et al.  Pathogenesis of Placental Site Trophoblastic Tumor May Require the Presence of a Paternally Derived X Chromosome , 2000, Laboratory Investigation.

[235]  K. Benirschke,et al.  Placental Pathology Casebook: Asymptomatic Intraplacental Choriocarcinoma Diagnosed on Routine Placental Examination , 1999, Journal of Perinatology.

[236]  N. Niikawa,et al.  Trizygotic pregnancy consisting of two fetuses and a complete hydatidiform mole with dispermic androgenesis. , 1999, American journal of medical genetics.

[237]  R. Kurman,et al.  Intermediate trophoblast: a distinctive form of trophoblast with specific morphological, biochemical and functional features. , 1984, Placenta.

[238]  R. Donehower,et al.  Plasma methotrexate levels in patients with gestational trophoblastic neoplasia treated by two methotrexate regimens. , 1984, American Journal of Obstetrics and Gynecology.

[239]  M. Glezerman,et al.  Choriocarcinoma associated with undetectable levels of human chorionic gonadotropin. , 1986, Gynecologic oncology.

[240]  A. Bagg,et al.  Gestational trophoblastic diseases. , 1996, Current opinion in obstetrics & gynecology.

[241]  A. McCourty,et al.  Immunohistochemical Expression of Cell Cycle Proteins E2F-1, Cdk-2, Cyclin E, p27kip1, and Ki-67 in Normal Placenta and Gestational Trophoblastic Disease , 2001, Modern Pathology.

[242]  R. Berkowitz,et al.  DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases , 1998, Oncogene.

[243]  M. Qumsiyeh,et al.  Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma. , 2000, Cancer genetics and cytogenetics.

[244]  S. Mccarthy,et al.  Nonmetastatic gestational trophoblastic neoplasia. Role of ultrasonography and magnetic resonance imaging. , 1998, The Journal of reproductive medicine.

[245]  H. Wallenburg,et al.  Choriocarcinoma with lung metastases during pregnancy with successful delivery and outcome after chemotherapy. , 1990, Thorax.

[246]  K. Tham,et al.  The classification of gestational trophoblastic disease: a critical review , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[247]  N. Sebire,et al.  The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[248]  P. Sand,et al.  Repeat Gestational Trophoblastic Disease , 1984, Obstetrics and gynecology.

[249]  A. Munkarah,et al.  Intraplacental Choriocarcinoma Associated with Viable Pregnancy: Pathologic Features and Implications for the Mother and Infant , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[250]  V. Sivanesaratnam,et al.  Malignant Evolution with Fatal Outcome in a Patient with Partial Hydatidiform Mole , 1981, The Australian & New Zealand journal of obstetrics & gynaecology.

[251]  M. Mazur,et al.  Fatal gestational trophoblastic disease: an analysis of treatment failures. , 1982, American journal of obstetrics and gynecology.

[252]  R. Berkowitz,et al.  Recent advances in gestational trophoblastic disease. , 1998, Current opinion in obstetrics & gynecology.

[253]  M. Seckl,et al.  Choriocarcinoma and partial hydatidiform moles , 2000, The Lancet.

[254]  R. Berkowitz,et al.  Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. , 1993, American journal of obstetrics and gynecology.

[255]  F. Parazzini,et al.  The epidemiology of gestational trophoblastic disease. , 1997, General & diagnostic pathology.

[256]  A. Cheung,et al.  Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase‐related M30 CytoDeath antibody , 2001, Histopathology.

[257]  R. Fisher,et al.  Recent advances in gestational trophoblastic disease. , 1999, Hematology/oncology clinics of North America.

[258]  S. J. Kim,et al.  Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. , 1998, Gynecologic oncology.

[259]  J. Felix,et al.  Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles. , 2001, American journal of obstetrics and gynecology.

[260]  R. Harris Correlation of postpartum intravenous pyelograms with clinical localization of antepartum pyelonephritis. , 1981, American journal of obstetrics and gynecology.

[261]  D. Fortune,et al.  Placental site trophoblastic tumor. Report of three cases and review of the literature , 1995, International Journal of Gynecologic Cancer.

[262]  R. Osathanondh,et al.  Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms. , 1978, Obstetrics and gynecology.

[263]  W. O,et al.  Expression of E-Cadherin and Beta-Catenin in Trophoblastic Tissue in Normal and Pathological Pregnancies , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[264]  A. Kriplani,et al.  Term twin pregnancy with hydatidiform mole and a normal fetus , 1999, Archives of Gynecology and Obstetrics.

[265]  U. Surti,et al.  Dispermic origin and clinical outcome of three complete hydatidiform moles with 46,XY karyotype. , 1982, American journal of obstetrics and gynecology.

[266]  S. Limpongsanurak Prophylactic actinomycin D for high-risk complete hydatidiform mole. , 2001, The Journal of reproductive medicine.

[267]  A. Berchuck,et al.  Alternating weekly chemotherapy with etoposide‐methotrexatedactinomycin/cyclophosphamide‐vincristine for high‐risk gestational trophoblastic disease , 1994, Obstetrics and gynecology.

[268]  T. Hassold,et al.  Very early complete hydatidiform mole. , 1996, Human pathology.

[269]  G. Coukos,et al.  Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy. , 2000, Gynecologic oncology.

[270]  M. Rettenmaier,et al.  Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.

[271]  R. Berkowitz,et al.  Oral Contraceptives and Postmolar Trophoblastic Disease , 1981, Obstetrics and gynecology.

[272]  G. Plant,et al.  Metastatic choriocarcinoma presenting as multiple intracerebral haemorrhages: the role of imaging in the elucidation of the pathology , 1998, Journal of neurology, neurosurgery, and psychiatry.

[273]  B. Yuen,et al.  Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy. , 1983, American journal of obstetrics and gynecology.

[274]  A. Lim,et al.  Embolization of bleeding residual uterine vascular malformations in patients with treated gestational trophoblastic tumors. , 2002, Radiology.

[275]  U. Surti,et al.  The Clinicopathologic Profile of the Partial Hydatidiform Mole , 1982, Obstetrics and gynecology.

[276]  R. Berkowitz,et al.  Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. , 2002, The Journal of reproductive medicine.

[277]  G. A. Stringer,et al.  Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease , 1986, Cancer.

[278]  M. Seoud,et al.  Genetic mapping of a maternal locus responsible for familial hydatidiform moles. , 1999, Human molecular genetics.

[279]  B. Hancock,et al.  A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[280]  B. Bigelow Gestational Trophoblast Disease , 1982 .

[281]  R. Coleman,et al.  Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role? , 1999, British Journal of Cancer.

[282]  R. Berkowitz,et al.  Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. , 2001, Gynecologic oncology.

[283]  I. Shih,et al.  Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. , 2002, The American journal of pathology.

[284]  H. Fox,et al.  Intraplacental choriocarcinoma: a report of two cases. , 1988, Journal of clinical pathology.

[285]  S. Heifetz,et al.  In situ choriocarcinoma arising in partial hydatidiform mole: implications for the risk of persistent trophoblastic disease. , 1992, Pediatric pathology.

[286]  F. Montz,et al.  The Natural History of Theca Lutein Cysts , 1988, Obstetrics and gynecology.

[287]  D. Brahams The evils of delay. , 1987, Lancet.

[288]  R. Berkowitz,et al.  Recent advances in molecular biology of gestational trophoblastic diseases. A review. , 2002, The Journal of reproductive medicine.

[289]  G. Rustin,et al.  Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[290]  E. Kohorn Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia. , 1993, Gynecologic Oncology.

[291]  I. Shih,et al.  The pathology of intermediate trophoblastic tumors and tumor-like lesions. , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[292]  G J S Rustin,et al.  The management of high‐risk gestational trophoblastic tumours (GTT) , 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[293]  C. Kong,et al.  Epithelioid Trophoblastic Tumor of the Uterus in a Postmenopausal Woman: A Case Report and Review of the Literature , 2000, The American journal of surgical pathology.

[294]  O. Gemer,et al.  The current clinical presentation of complete molar pregnancy , 2000, International Journal of Gynecologic Cancer.

[295]  D. Grimes,et al.  Epidemiology of hydatidiform mole during early gestation. , 1986, American journal of obstetrics and gynecology.

[296]  Patricia A. Jacobs,et al.  Mechanism of origin of complete hydatidiform moles , 1980, Nature.

[297]  R. Berkowitz,et al.  Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. , 1998, The Journal of reproductive medicine.

[298]  K. Ohama,et al.  Androgenetic origin of hydatidiform mole , 1977, Nature.

[299]  A. Rademaker,et al.  Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high‐risk gestational trophoblastic disease , 1992, Obstetrics and gynecology.

[300]  E. Gloor,et al.  Trophoblastic pseudotumor of the uterus: Clinicopathologic report with immunohistochemical and ultrastructural studies , 1981, The American journal of surgical pathology.

[301]  R. Fisher,et al.  A prospective genetic study of complete and partial hydatidiform moles. , 1991, American journal of obstetrics and gynecology.

[302]  R. Coleman,et al.  Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. , 2000, Gynecologic oncology.

[303]  B. Halpern,et al.  Gestational trophoblastic disease: selected clinical aspects and chorionic gondadotropin test methods. , 1979, Current problems in cancer.

[304]  S. J. Kim,et al.  Telomerase activity in complete hydatidiform mole. , 1999, American journal of obstetrics and gynecology.

[305]  N. Sebire,et al.  Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age , 2002, BJOG : an international journal of obstetrics and gynaecology.

[306]  M. Hashimoto [The propensity to malignancy of dispermic, heterozygous moles]. , 1987, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[307]  K. Bagshawe,et al.  RELATIONSHIP OF ORAL CONTRACEPTION TO DEVELOPMENT OF TROPHOBLASTIC TUMOUR AFTER EVACUATION OF A HYDATIDIFORM MOLE , 1976, British journal of obstetrics and gynaecology.

[308]  M. Yokoyama,et al.  Epithelioid trophoblastic tumor of the uterus: Cytological and immunohistochemical observation of a case , 2002, Pathology international.

[309]  M. Hoffman,et al.  A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. , 1996, Gynecologic oncology.

[310]  R. Scully,et al.  Trophoblastic pseudotumor of the uterus. An exaggerated form of “syncytial endometritis” simulating a malignant tumor , 1976, Cancer.

[311]  J. Lurain Management of high-risk gestational trophoblastic disease. , 1998, The Journal of reproductive medicine.

[312]  J. Lewis,et al.  Gestational trophoblastic neoplasms. , 1974, Gynecologic oncology.

[313]  E. Newlands,et al.  Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[314]  J. Buckley The Epidemiology of Molar Pregnancy and Choriocarcinoma , 1984, Clinical obstetrics and gynecology.

[315]  W. Jones Trophoblastic tumors—prognostic factors , 1981, Cancer.

[316]  S. Sasaki,et al.  Genesis of 46,XY hydatidiform mole. , 1981, American journal of obstetrics and gynecology.

[317]  B. Nisula,et al.  Thyroid function in gestational trophoblastic neoplasia: evidence that the thyrotropic activity of chorionic gonadotropin mediates the thyrotoxicosis of choriocarcinoma. , 1980, American journal of obstetrics and gynecology.

[318]  H. Ma,et al.  Primary oral etoposide therapy in gestational trophoblastic disease: An update , 1986, Cancer.

[319]  J. Lewis,et al.  Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. , 1961, American journal of obstetrics and gynecology.

[320]  R. Conran,et al.  Diagnostic considerations in molar gestations. , 1993, Human pathology.

[321]  M. Rettenmaier,et al.  Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease , 1988, Obstetrics and gynecology.

[322]  Rose Pg,et al.  Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease. , 1989 .

[323]  P. Wu,et al.  Re-evaluation of 5-fluorouracil as a single agent for gestational malignant trophoblastic neoplasms. , 1984, Advances in Experimental Medicine and Biology.

[324]  L. Twiggs,et al.  A Prospective Randomized Comparison of Methotrexate, Dactinomycin, and Chlorambucil Versus Methotrexate, Dactinomycin, Cyclophosphamide, Doxorubicin, Melphalan, Hydroxyurea, and Vincristine in “Poor Prognosis” Metastatic Gestational Trophoblastic Disease: A Gynecologic Oncology Group Study , 1989, Obstetrics and gynecology.

[325]  H Fox,et al.  Pathology of the placenta. , 1986, Major problems in pathology.

[326]  Kohorn Ei Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. , 1982 .

[327]  J. Weed,et al.  Cerebral metastatic choriocarcinoma: intensive therapy and prognosis. , 1980, Obstetrics and gynecology.

[328]  R. Nakamura,et al.  The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. , 1985, American journal of obstetrics and gynecology.

[329]  Y. Soong,et al.  Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. , 1999, Gynecologic oncology.

[330]  R. Berkowitz,et al.  Pathogenesis of gestational trophoblastic neoplasms. , 1981, Pathobiology annual.

[331]  H. Ngan,et al.  Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[332]  S. Takeuchi,et al.  Clinical evaluation of focal excision of myometrial lesion for treatment of invasive hydatidiform mole , 1988, Acta obstetricia et gynecologica Scandinavica.

[333]  S. Kramer,et al.  Assessment of the long‐term effects of primary radiation. Therapy for brain tumors in children , 1982, Cancer.

[334]  J. Palmer,et al.  Advances in the epidemiology of gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.

[335]  C. Azuma,et al.  A new approach using DNA fingerprinting for the determination of androgenesis as a cause of hydatidiform mole. , 1989, Placenta.

[336]  S. Povey,et al.  GENETIC STUDIES OF COMPLETE AND PARTIAL HYDATIDIFORM MOLES , 1979, The Lancet.

[337]  D. Grimes Epidemiology of gestational trophoblastic disease. , 1984, American journal of obstetrics and gynecology.

[338]  A. Berchuck,et al.  5-day methotrexate for women with metastatic gestational trophoblastic disease. , 1994, Gynecologic oncology.

[339]  J. Goldfarb,et al.  Reproductive performance of patients after gestational trophoblastic disease. , 1995, Seminars in Oncology.

[340]  G. Rustin,et al.  Respiratory failure due to choriocarcinoma: a study of 103 dyspneic patients. , 1990, Gynecologic oncology.

[341]  J. Lewis,et al.  Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. , 1996, Gynecologic oncology.

[342]  P. Wu,et al.  Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up. , 1988, American journal of obstetrics and gynecology.

[343]  T. Gibson,et al.  THE CONTAMINATED DROP. , 1965, Lancet.

[344]  R. Berkowitz,et al.  The Changing Clinical Presentation of Complete Molar Pregnancy , 1995, Obstetrics and gynecology.

[345]  J. Lage Gestational trophoblastic tumors: refining histologic diagnoses by using DNA flow and image cytometry. , 1994, Current opinion in obstetrics & gynecology.

[346]  M. Amer,et al.  Liver metastases of gestational trophoblastic tumor. , 1993, Gynecologic oncology.

[347]  G. Crépin,et al.  [Treatment of trophoblastic tumors]. , 1971, Revue francaise de gynecologie et d'obstetrique.

[348]  M. Fukunaga Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. , 2002, Human pathology.

[349]  E. Surwit,et al.  Choriocarcinoma Following Term Pregnancy , 1979, Obstetrics and gynecology.

[350]  J. Weed,et al.  Choriocarcinoma metastatic to the brain: therapy and prognosis. , 1982, Seminars in oncology.

[351]  M. Wells,et al.  Over‐diagnosis of hydatidiform mole in early tubal ectopic pregnancy , 2001, Histopathology.

[352]  J. Weed,et al.  Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid. , 1982, American journal of obstetrics and gynecology.

[353]  H. Ushijima,et al.  Histopathologic classification of uterine choriocarcinoma , 1985, Cancer.

[354]  U. Surti,et al.  The Syndromes of Partial and Complete Molar Gestation , 1984, Clinical obstetrics and gynecology.

[355]  P. Disaia,et al.  Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. , 1977, American journal of obstetrics and gynecology.

[356]  Bagshawe Kd Treatment of high-risk choriocarcinoma. , 1984 .

[357]  J. Schlaerth,et al.  Prognostic Characteristics of Serum Human Chorionic Gonadotropin Titer Regression Following Molar Pregnancy , 1981, Obstetrics and gynecology.

[358]  A. Gown,et al.  Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease. , 1994, American journal of obstetrics and gynecology.

[359]  R. Berkowitz,et al.  Brain metastases of gestational trophoblastic tumor. , 1992, The Journal of reproductive medicine.

[360]  D. Roberts,et al.  A second case of "chorangiocarcinoma" presenting in a term asymptomatic twin pregnancy: choriocarcinoma in situ with associated villous vascular proliferation. , 1994, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[361]  S. J. Kim,et al.  Subsequent reproductive experience after treatment for gestational trophoblastic disease. , 1998, Gynecologic oncology.

[362]  J. Lurain,et al.  Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. , 1995, American journal of obstetrics and gynecology.

[363]  G. Rustin,et al.  Gestational trophoblastic disease with liver metastases: the Charing Cross experience , 1997, British journal of obstetrics and gynaecology.

[364]  R. Berkowitz,et al.  Pulmonary metastases of gestational trophoblastic tumor. Risk factors for early respiratory failure. , 1994, The Journal of reproductive medicine.

[365]  J. Schlaerth,et al.  Diagnostic and therapeutic curettage in gestational trophoblastic disease. , 1990, American journal of obstetrics and gynecology.

[366]  M. Evans,et al.  PERSISTENCE OF PARTIAL MOLAR PLACENTA AND SEVERE PREECLAMPSIA AFTER SELECTIVE TERMINATION IN A TWIN PREGNANCY , 1996, Obstetrics and gynecology.

[367]  R. Romero,et al.  New Criteria for the Diagnosis of Gestational Trophoblastic Disease , 1985, Obstetrics and gynecology.

[368]  D. Clarke‐Pearson,et al.  Metastatic Gestational Trophoblastic Disease: Prognostic Factors in Previously Untreated Patients , 1988, Obstetrics and gynecology.

[369]  R. Kurman,et al.  Gestational Trophoblastic Disease and Related Lesions , 1994 .

[370]  J. Lage Diagnostic dilemmas in gynecologic and obstetric pathology. , 1990, Seminars in diagnostic pathology.

[371]  H. Ma,et al.  Residual trophoblastic disease in association with partial hydatidiform mole. , 1981, Obstetrics and gynecology.

[372]  E. Surwit,et al.  Poor‐Prognosis Gestational Trophoblastic Disease: An Update , 1984, Obstetrics and gynecology.

[373]  A. Berchuck,et al.  Gestational trophoblastic disease metastatic to the central nervous system. , 1995, Gynecologic oncology.

[374]  A. Berchuck,et al.  Evaluation of Prognostic Factors and Staging in Gestational Trophoblastic Tumor , 1994, Obstetrics and gynecology.

[375]  Hammond Cb,et al.  Diagnosis and treatment of trophoblastic disease. A report from the Southeastern Regional Center. , 1970 .

[376]  R. Berkowitz,et al.  Natural history of postterm choriocarcinoma. , 1998, The Journal of reproductive medicine.

[377]  T. Stallmach,et al.  Incidental choriocarcinoma confined to a near-term placenta , 1998, Virchows Archiv.

[378]  J. Garay,et al.  Sex assignment in gestational trophoblastic neoplasia. , 1984, American journal of obstetrics and gynecology.

[379]  R. Woolas,et al.  Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome , 1998, British journal of obstetrics and gynaecology.

[380]  E. Raymond,et al.  Efficacy of the metastatic survey in the staging of gestational trophoblastic disease , 1990, Cancer.

[381]  T Gül,et al.  A review of trophoblastic diseases at the medical school of Dicle University. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[382]  R. Berkowitz,et al.  Sonographic appearance of first trimester complete hydatidiform moles , 2000, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[383]  Szulman Ae Syndromes of hydatidiform moles. Partial vs. complete. , 1984 .

[384]  M. Bracken,et al.  Hydatidiform mole in the United States (1970-1977): a statistical and theoretical analysis. , 1982, American journal of epidemiology.

[385]  R. Berkowitz,et al.  Persistent gestational trophoblastic tumor after partial hydatidiform mole. , 1990, Gynecologic oncology.

[386]  R. Scully,et al.  Placental Site Nodules and Plaques A Clinicopathologic Analysis of 20 Cases , 1990, The American journal of surgical pathology.

[387]  R. Scully,et al.  A distinctive glomerular lesion complicating placental site trophoblastic tumor: report of two cases. , 1985, Human pathology.

[388]  J. Cairncross,et al.  Radation therapy for brain metastases , 1980 .

[389]  F. L. La Rosa,et al.  Molar pregnancy in a 60‐year‐old woman , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[390]  R. Berkowitz,et al.  Reproductive Performance After Molar Pregnancy and Gestational Trophoblastic Tumors , 1984, Clinical obstetrics and gynecology.

[391]  E. Newlands,et al.  A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non‐molar hydropic abortions , 1996, Histopathology.

[392]  C. Elston The histopathology of trophoblastic tumours , 1976, Journal of clinical pathology. Supplement.

[393]  M. Fukunaga,et al.  Application of flow cytometry in diagnosis of hydatidiform moles. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.